Bioventus is a global medical device company that develops and sells clinically-proven solutions for pain relief and musculoskeletal disorders across three therapeutic areas: pain treatments and platelet-rich plasma therapies, surgical solutions including ultrasonic systems and bone graft substitutes, and restorative therapies for bone healing. The company markets its products to physician offices, ambulatory surgical centers, and hospitals across specialties including orthopedics, spine, trauma, and neurosurgery, with approximately 88% of sales from the U.S. market and the remainder from international operations through both direct sales teams and distributor channels. Bioventus generates revenue through product sales reimbursed by government programs such as Medicare and Medicaid as well as private insurance payers, and competes on product features, clinical evidence, reimbursement coverage, and pricing against larger medical device manufacturers.